U.S. Trade Distributors Stock News

Paysafe (PSFE) has wrapped up FY 2025 with fourth quarter revenue of US$438.4 million and a basic EPS loss of US$0.45, alongside trailing 12 month revenue of about US$1.7 billion and a basic EPS loss of US$3.14. Over recent periods, the company has seen quarterly revenue move between US$401 million and US$438.4 million, while quarterly basic EPS has ranged from a loss of US$1.52 to a loss of US$0.33. This sets up a mixed picture on profitability that investors will be weighing against the...

Earnings snapshot: mixed revenue picture with improved quarterly profitability MP Materials (MP) reported fourth quarter 2025 sales of US$52.69 million compared with US$60.99 million a year earlier, with net income of US$9.43 million versus a net loss of US$22.34 million. For the full year, sales were US$224.44 million compared with US$203.86 million, while the company recorded a net loss of US$85.87 million compared with a net loss of US$65.42 million in the prior year. See our latest...

Adelante Capital Management has made a substantial reduction in its holdings of NYSE:BXP. BXP reports strong progress on its multi year business plan, including significant leasing activity, a major sales program, and key development milestones. These moves highlight changing institutional positioning in BXP alongside company actions to reshape its portfolio and execute on long term priorities. For you as an investor, this combination of a large shareholder cutting exposure and BXP...

AnaptysBio's FY 2025 Headline Numbers AnaptysBio (ANAB) has put up a sharp swing in its latest quarter, with Q4 FY 2025 revenue at US$108.2 million and basic EPS of US$1.79, compared with a loss in the same quarter a year earlier and a trailing twelve month basic EPS of US$0.46 loss on revenue of US$234.6 million. Over recent periods, the company has seen quarterly revenue move from US$43.1 million in Q4 2024 to US$22.3 million in Q2 2025 and US$76.3 million in Q3 2025 before reaching...

If you are wondering whether Trane Technologies at around US$445 per share still offers fair value, you are not alone. A closer look at the numbers can help frame that question clearly. The stock has seen a 3.3% decline over the last 7 days, a 4.7% gain over 30 days, an 11.8% return year to date, 28.9% over 1 year and 139.8% over 3 years. These figures can influence how you think about both its potential and the current level of risk. Recent headlines have focused on Trane Technologies as a...

Rigel Pharmaceuticals (RIGL) capped FY 2025 with Q4 total revenue of US$69.8 million and basic EPS of US$14.72, while trailing twelve month figures show revenue of US$294.3 million and EPS of US$20.40, all tied to net income excluding extra items of US$367.0 million. Over the past few reported quarters, revenue has ranged from US$53.3 million to US$101.7 million and quarterly EPS has moved from US$0.64 to US$14.72. This sets up a year in which trailing earnings growth was very large and net...

Cognizant Technology Solutions (NasdaqGS:CTSH) announced a new partnership with Google Cloud to scale enterprise AI and automation initiatives using Gemini Enterprise and Google Workspace. The company also entered a multi-year agreement with a leading global commercial vehicle manufacturer to deliver AI powered workplace transformation across its operations. Both announcements highlight Cognizant's focus on AI driven services for large enterprise clients across industries. Cognizant...

If you are looking at Clorox and wondering whether the current price really reflects what the business is worth, this article is going to walk you through that question step by step. The stock recently closed at US$117.43, with returns of 3.7% over the last 30 days, a 16.4% gain year to date, an 18.4% decline over the past year and a 26.9% decline across five years, which may have shifted how investors view its potential and risk. Recent coverage of Clorox has focused on how the company is...

In February 2026, DRDGOLD reported strong interim results for the six months ended 31 December 2025, generating higher cash despite a gold production drop linked to weather disruptions and advancing its Vision 2028 projects connecting Ergo to Daggafontein and progressing regulatory work at Withok TSF. A key takeaway is that favourable gold prices have enabled DRDGOLD to reinvest in life-extending infrastructure while preserving a robust, debt-light financial position. We’ll now examine how...

If you are asking whether Webull is attractively priced or simply a cheap stock for a reason, you are in the right place to start unpacking its valuation story. Webull last closed at US$6.07, with a 1% return over the past week, a 10.7% decline over 30 days, and a 25.9% decline year to date. These moves add extra focus on what that price really reflects. Recent coverage of online trading platforms has highlighted investor attention on user growth, trading activity, and regulatory...

Trade Desk (TTD) is back in focus after Q4 results beat expectations, but Q1 2026 guidance pointed to slower growth and lower adjusted EBITDA, triggering a sharp rethink of the stock’s near term outlook. See our latest analysis for Trade Desk. The mixed Q4 print and softer Q1 2026 outlook come after a tough run for shareholders, with a 30 day share price return of 17.57% and a 90 day share price return of 35.25%. The 1 year total shareholder return of 63.02% underscores how sentiment has...

Old Second Bancorp (OSBC) is set to redeem $30 million of its 3.50% subordinated notes due 2031 on April 15, 2026, following non objection from the Federal Reserve Bank of Chicago. See our latest analysis for Old Second Bancorp. The news of the subordinated note redemption comes as Old Second Bancorp’s share price sits at $20.05, with a 90 day share price return of 2.14% and a 1 year total shareholder return of 16.72%. This indicates that momentum has been gradually building over a multi year...

If you are wondering whether Ciena's share price still lines up with its underlying worth, this article will walk through what the current numbers actually say about value. Ciena's stock recently closed at US$343.55, after a 28.0% gain over the last 30 days, a 39.6% return year to date, and very large returns over 1 and 5 years, despite a 2.8% pullback in the last week. Recent headlines around Ciena have focused on the company as a key player in optical networking and telecom equipment, with...

If you are wondering whether Dana's share price still offers value after a strong run, the key question now is how the current price lines up with the company's underlying fundamentals. The stock recently closed at US$34.21, with returns of 16.0% over 30 days, 37.1% year to date, 142.0% over 1 year, 134.1% over 3 years, and 49.7% over 5 years, although the last 7 days showed a 4.4% decline. Recent news coverage has focused on Dana's position in the auto parts and driveline space and how...

Why Central Garden & Pet is on investors’ radar today Central Garden & Pet (CENT) has attracted fresh attention after recent share price moves, with the stock showing a mix of short term volatility and stronger performance over the month and past 3 months. See our latest analysis for Central Garden & Pet. That recent 11.46% 1 month share price return and 14.58% 3 month share price return build on a 20.28% year to date share price gain. The 1 year total shareholder return of 7.38% and 3 year...

AvalonBay Communities recently authorized a new share repurchase program of up to US$1.00 billion with no expiration date, while also filing its 2025 Form 10-K detailing expansion into new metropolitan regions and ongoing portfolio management through acquisitions, developments, and sales. By pairing a sizeable, open-ended buyback authorization with an emphasis on capital flexibility and market expansion, management is underscoring its conviction in the company’s long-term positioning and its...

If you are wondering whether Intercontinental Exchange's current share price still lines up with its underlying value, you are not alone. This article is built to help you connect the dots. The stock most recently closed at US$166.29, with returns of 3.7% over the past week, a 4.0% decline over the past month, 3.9% year to date, a 2.0% decline over the past year and gains of 68.5% over three years and 53.4% over five years. These mixed short and long term moves have kept valuation in focus...

Olin Corporation recently closed its long-standing US$36.99 million shelf registration tied to a 2,250,000-share ESOP-related common stock offering and affirmed a regular quarterly cash dividend of US$0.20 per share, paid on March 13, 2026 to shareholders of record on March 3, 2026. This comes shortly after Olin warned that preliminary Q4 2025 adjusted EBITDA would fall well below earlier expectations due to resolved operational disruptions and softer chlorine demand, while management shifts...

In late February 2026, Navitas Semiconductor reported full-year 2025 sales of US$45.92 million with higher losses, announced the planned departure of CFO and Treasurer Todd Glickman, and highlighted new AI data center and grid-focused power technologies it will showcase at APEC 2026 and through its solid-state transformer collaboration with EPFL. A key angle for investors is how Navitas is pairing deeper losses and leadership change with an aggressive push into AI data center and...

Lazard has expanded its Healthcare Group with the addition of senior Managing Directors John Koski and Rob Lowe. Both hires bring extensive experience in healthcare advisory and leadership from established firms. Lazard, listed as NYSE:LAZ, is putting more weight behind its healthcare advisory franchise by hiring John Koski and Rob Lowe into its Healthcare Group. The stock last closed at $48.39, with a 1 year return of 4.2% and a 3 year return of 49.9%. Over 5 years, the share price return...

In recent weeks, AMD and Meta announced a 6‑gigawatt agreement to power Meta’s next generation of AI infrastructure using custom AMD Instinct GPUs and 6th Gen EPYC CPUs, expanding a long‑running hardware and software collaboration across data center scale. By locking in multi‑generation AI compute with AMD while also diversifying across other chip partners, Meta is effectively reshaping its long‑term AI supply chain and technical stack around hyperscale, AI‑first operations. We’ll now...

A class action lawsuit has been filed against Stifel Financial Corp. alleging long term mismanagement of its 401(k) retirement plan. The suit claims the company failed to remove persistently underperforming investment funds, raising questions about its ERISA fiduciary practices. The litigation focuses on Stifel's role as a plan sponsor and its responsibilities to employees and plan beneficiaries. For investors tracking Stifel Financial (NYSE:SF), this lawsuit comes at a time when the stock...

Atlanta store opening and what it might mean for Wayfair stock Wayfair (W) is back in focus after announcing its second large format physical store, a roughly 150,000 square foot location in Atlanta, with grand opening events set for mid April. This push into brick and mortar comes shortly after improved full year 2025 results. Sales reached US$12.457b and the company reported a net loss of US$313 million, alongside upbeat commentary from Optimist Fund on recent quarterly performance. See our...

If you are wondering whether Vertex Pharmaceuticals is still reasonably priced after its big run in recent years, you are not alone. This article is here to help you weigh what you are actually paying for. The share price closed at US$477.89 recently, with returns of 5.7% year to date, 67.6% over 3 years and 123.0% over 5 years. However, the last year saw a 2.8% decline and the last 7 days a 1.1% decline. Recent headlines have focused on Vertex as a large, established biotech name, often...